BTK inhibitors appear to be most valuable in isolation therapy for cases of drug resistant MM, as the BTK pathway appears to be selectively upregulated in these phenotypes [72], and in preventing relapse or disease progression. This evidence concerns the gene BTK and Miyoshi myopathy.